Australia markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
4.3500-0.0200 (-0.46%)
At close: 04:00PM EDT
4.3600 +0.01 (+0.23%)
After hours: 06:11PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,157,600
1,023,000
1,076,100
1,639,400
1,462,200
Cost of revenue
697,100
705,400
693,100
748,100
537,000
Gross profit
460,500
317,600
383,000
891,300
925,200
Operating expenses
Research development
85,800
111,400
188,300
235,200
237,900
Selling general and administrative
351,800
368,400
339,500
348,700
304,100
Total operating expenses
474,600
519,100
546,300
508,200
486,700
Operating income or loss
-14,100
-201,500
-163,300
383,100
438,500
Interest expense
94,300
87,900
37,300
34,500
31,300
Total other income/expenses net
-450,100
-441,800
-18,400
-45,400
4,700
Income before tax
-558,500
-731,200
-219,000
303,200
411,900
Income tax expense
6,800
29,300
-7,400
83,700
106,100
Income from continuing operations
-565,300
-760,500
-211,600
219,500
305,800
Net income
-565,300
-760,500
-211,600
219,500
305,800
Net income available to common shareholders
-565,300
-760,500
-211,600
219,500
305,800
Basic EPS
-15.56
-14.85
-4.22
4.10
5.80
Diluted EPS
-15.56
-14.85
-4.22
4.06
5.68
Basic average shares
50,625
51,200
50,100
53,500
52,700
Diluted average shares
50,625
51,200
50,100
54,100
53,800